Substituted 1,4-naphthoquinones vs. the ascitic sarcoma 180 of mice
- 1 April 1983
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 26 (4) , 570-574
- https://doi.org/10.1021/jm00358a021
Abstract
Twelve 1,4-naphthoquinones were tested against the ascitic form of sarcoma 180 in Swiss mice. Statistical analysis shows that the most important molecular parameter determining their effectiveness in prolonging the life of mice bearing this tumor is their redox potentials. Although the toxicities of the compounds are also related to the redox potentials in the same way, the therapeutic indexes can be increased by adding substituents of greater lipophilicity. The naphthoquinones differ greatly in antitumor activities and may inhibit the growth of malignant cells by different mechanisms.This publication has 8 references indexed in Scilit:
- Water solubility and octanol/water partition coefficients of organics. Limitations of the solubility-partition coefficient correlationEnvironmental Science & Technology, 1980
- Solubility and partitioning I: Solubility of nonelectrolytes in waterJournal of Pharmaceutical Sciences, 1980
- Dichloroallyl lawsoneClinical Pharmacology & Therapeutics, 1979
- Discriminant analysis and structure-activity relationships. 1. NaphthoquinonesJournal of Medicinal Chemistry, 1978
- INVESTIGATION OF STRUCTURE-FUNCTION-RELATIONSHIPS OF CYTOTOXIC QUINONES OF NATURAL AND SYNTHETIC ORIGIN1978
- 199 - Electrochemical investigations into the effect of quinones on Ehrlich ascites tumor cells of mice III. Cyclic voltammetry of quinones in aqueous solution. Use of the R.D.E. for the evaluation of the reaction kinetics of various quinone compounds with tumor cellsBioelectrochemistry and Bioenergetics, 1978
- Antitumor activity of shikonin and its derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1977
- Potential bioreductive alkylating agents—VI. Determination of the relationship between oxidation-reduction potential and antineoplastic activityBiochemical Pharmacology, 1976